CLINICAL_TRIALS
trial_result
· 2023-12-08
Clinical Trial Update: A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN) [Phase 2]
Summary
The Phase 2 trial of cemdisiran in adults with immunoglobulin A nephropathy (IgAN) has been terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alnylam Pharmaceuticals | Conditions: IgA Nephropathy (IgAN), Berger Disease | Phase 2 | Status: TERMINATED | Results posted: 2023-12-08